Elsevier

DNA Repair

Volume 96, December 2020, 102971
DNA Repair

Towards DNA-damage induced autophagy: A Boolean model of p53-induced cell fate mechanisms

https://doi.org/10.1016/j.dnarep.2020.102971Get rights and content

Highlights

  • First synthetic gene network of multiple cell fates induced by DNA damage based on the U87 glioblastoma cell line.

  • The model describes cell fate determination for three phenotypes: apoptosis, senescence and autophagy.

  • The model was generalized to describe other three different cell lines: MCF-7, A549 and U2OS.

  • For p53-deficient cell lines the model contemplates the alternative AMPK pathway which compensates this deficiency.

  • The approach is useful for designing experiments of loss and gain of function perturbations to induce a specific phenotype.

Abstract

How a cell determines a given phenotype upon damaged DNA is an open problem. Cell fate decisions happen at cell cycle checkpoints and it is becoming clearer that the p53 pathway is a major regulator of cell fate decisions involving apoptosis or senescence upon DNA damage, especially at G1/S. However, recent results suggest that this pathway is also involved in autophagy induction upon DNA damage. To our knowledge, in this work we propose the first model of the DNA damage-induced G1/S checkpoint contemplating the decision between three phenotypes: apoptosis, senescence, and autophagy. The Boolean model is proposed based on experiments with U87 glioblastoma cells using the transfection of miR-16 that can induce a DNA damage response. The wild-type case of the model shows that DNA damage induces the checkpoint and the coexistence of the three phenotypes (tristable dynamics), each with a different probability. We also predict that the positive feedback involving ATM, miR-16, and Wip1 has an influence on the tristable state. The model predictions were compared to experiments of gain and loss of function in other three different cell lines (MCF-7, A549, and U2OS) presenting agreement. For p53-deficient cell lines such as HeLa, H1299, and PC-3, our model contemplates the experimental observation that the alternative AMPK pathway can compensate this deficiency. We conclude that at the G1/S checkpoint the p53 pathway (or, in its absence, the AMPK pathway) can regulate the induction of different phenotypes in a stochastic manner in the U87 cell line and others.

Introduction

It is well known that Tumor suppressor p53 protein (p53) is the master regulator of cell fate in response to DNA damage (see latest review by Hafner [1]). Low levels of p53 induce cell cycle arrest and/or senescence, whereas high levels induce cell death pathways [2]. However, inactivation of p53-mediated-cell death is a major step in tumor development [3]. While a role for the p53 pathway in apoptosis is better established [4], its involvement in the induction of autophagy is not fully understood. Our main interest here is to explain how DNA damage induces a given cell phenotype.

Several studies show that the DNA damage-regulated autophagy modulator 1 (DRAM1), which is regulated by p53, modulates autophagy in response to DNA damage [[5], [6], [7], [8], [9]]. This molecule seems to represent the link between the p53 pathway and autophagy induction (see the review by Mathiassen [10]). The study of Mauthe et al. [11] revealed that resveratrol-mediated autophagy depends on the downregulation of Wip1 (protein phosphatase, Mg2 + /Mn2 + dependent 1D), a p53 regulated gene in cancer cell lines such as U2OS cells and MCF-7 [11]. Zou and colleagues [12] showed that ATM (ATM serine/threonine kinase) is involved in autophagy of U87 cells [12]. Wip1 is a negative regulator of the ATM/p53 pathway, downregulation of Wip1 thereby increases this pathway activity and leads to the induction of the G1/S (and G2/M) cell cycle checkpoint, whereas its overexpression inhibits checkpoints induction [[13], [14], [15]].

In addition, the studies of Brichkina et al. [16] and Le Guezennec et al. [17] reported that the deletion or knockdown of Wip1 can activate autophagy via the ATM/AMPK/TSC2/mTORC (AMP-activated protein kinase, Tuberin, Mammalian target of rapamycin complex 1) signaling pathway. In more detail, ATM activates TSC2 via AMPK, and TSC2 inhibits mTOR inducing autophagy. Moreover, Oxidized low-density lipoprotein (OxLDL) promotes intracellular ROS production and induces oxidative DNA damage. OxLDL is a well-known regulator of cholesterol efflux in macrophages. Deletion or knockdown of Wip1 via OxLDL activated ATM-mediates atherosclerosis and is essential for the formation of foam cells and atherosclerotic plaques. Thus, these two studies suggested that the autophagy phenotype can be achieved via targeting of Wip1 in foam cells and atherosclerosis.

The MicroRNA-16 (miR-16) is a master regulator of tumor suppression and plays an essential role in response to DNA damage [18]. Lately, various studies show that the targeting of Wip1 by miR-16 can affect cell fate decision in cancer cells in response to DNA damage [[19], [20], [21], [22]]. Interestingly, Huang et al. found evidence that miR-16 is involved in autophagy induction [23]. Furthermore, miR-16 activation occurs through ATM-mediated transcription inhibiting Wip1 expression [18,20]. An already identified double-negative feedback loop involving ATM, miR-16, and Wip1 plays a role in the induction of autophagy in U2OS cells (and possibly in U87 cells) [18,20,24]. The information above suggests that these molecules play a role in autophagy regulation.

With the immense complexity of biological systems in terms of its interactive nature, the development of network-based models of these systems has been recognized as a valuable approach to study many biological processes [[25], [26], [27], [28]]. Particularly, Boolean models can provide an informative and coherent qualitative description of the network dynamics [29]. Experimentally testable predictions can be obtained using this method, which are associated to less-understood aspects of the integration of network analysis and dynamic modeling [30]. One of the main features of qualitative models is to study the influence of regulatory circuits (also known as feedback loops), which are closed paths between two or more nodes in the network. Determining the regulatory function of a circuit in the network can help to elucidate cell-fate decision processes.

Motivated by these facts, we developed a Boolean model of the G1/S checkpoint regulatory network (see Fig. 1) to investigate cell-fate induction contemplating three possible phenotypes: autophagy, apoptosis and senescence. To our knowledge this is the first model in the literature dealing with more than two phenotypes.

Section snippets

The Boolean formalism

The construction of the Boolean regulatory network is based on the published biochemical information about the molecules and their interactions (activatory or inhibitory) characterized by a directed graph. The variables values representing the state of the molecules are discrete taking only the values 0 or 1. A logical function defines the value of each node according to its regulatory nodes. The logical rules are built using the logical operators AND, OR, and NOT [31]. The activity of the

Network’s wild-type case dynamics

The network presents 4 states for the wild-type case (WT) dynamics which are associated each to a different phenotype, Fig. 2. The first state represents a proliferative case (corresponding to the input: Transfected − miRNA = OFF), i.e., no G1/S arrest as only cell cycle promoters are induced: CDK46/CycD, CDK2/CycE and Cdc25A. The other three states are coexistent cell cycle arrest states (tristable dynamics), i.e., they are induced by the same initial input: Transfected − miRNA = ON. The

Discussion and conclusions

In this work, we proposed a Boolean model of the G1/S checkpoint regulation. The WT case predicts that under DNA damage apoptosis, senescence or autophagy can be induced with probabilities that decrease in this order. Previously, we and others have shown that the p53 pathway is involved in the bistable senescence/apoptosis switch in cancer cells [2,[50], [51], [52]]. However, the role of the p53 pathway in a tristable dynamics is still unknown. This is first model connecting the p53 pathway

Author contributions

S.G., D.A.S., and J.C.M.M. conceived the experiment(s); S.G. and D.A.S. conducted the experiment(s); S.G., D.A.S., and J.C.M.M. analyzed the results. All authors reviewed the manuscript.

CRediT authorship contribution statement

Shantanu Gupta: Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Software, Validation, Visualization, Writing - original draft, Writing - review & editing. Daner A. Silveira: Conceptualization, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing - original draft, Writing - review & editing. José Carlos M. Mombach: Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Resources,

Declaration of Competing Interest

The authors declare that they have no conflict of interest

Acknowledgments

S. Gupta and D.A. Silveira acknowledge partial support from CAPES and CNPq, respectively. J.C.M. Mombach acknowledges useful discussions with Prof. Guido Lenz.

References (88)

  • M. Collado et al.

    Cellular senescence in cancer and aging

    Cell

    (2007)
  • G. Yang et al.

    A positive feedback loop between Akt and mTORC2 via SIN1 phosphorylation

    Cell Rep.

    (2015)
  • J.R. Pomerening

    Positive-feedback loops in cell cycle progression

    FEBS Lett.

    (2009)
  • C. Wang et al.

    Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

    Nat. Cell Biol.

    (2006)
  • G. Wan et al.

    DNA-damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathway

    Cell Rep.

    (2013)
  • B. Zhang et al.

    p53-dependent upregulation of miR-16-2 by sanguinarine induces cell cycle arrest and apoptosis in hepatocellular carcinoma

    Cancer Lett.

    (2019)
  • A. Hafner et al.

    The multiple mechanisms that regulate p53 activity and cell fate

    Nat. Rev. Mol. Cell Biol.

    (2019)
  • X.-P. Zhang et al.

    Two-phase dynamics of p53 in the DNA damage response

    Proc. Natl. Acad. Sci.

    (2011)
  • M. Hollstein et al.

    p53 mutations in human cancers

    Science

    (1991)
  • J.S. Fridman et al.

    Control of apoptosis by p53

    Oncogene

    (2003)
  • J. Guan et al.

    DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX

    Cell Death Dis.

    (2015)
  • X.-D. Zhang et al.

    DRAM1 regulates autophagy flux through lysosomes

    PLoS One

    (2013)
  • L. Cui et al.

    Radiation induces autophagic cell death via the p53/DRAM signaling pathway in breast cancer cells

    Oncol. Rep.

    (2016)
  • T. Lu et al.

    DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway

    Cell Commun. Signal.

    (2019)
  • S.G. Mathiassen et al.

    Autophagy and the Cell Cycle: A Complex Landscape

    Front. Oncol.

    (2017)
  • M. Mauthe et al.

    Resveratrol-mediated autophagy requires WIPI-1-regulated LC3 lipidation in the absence of induced phagophore formation

    Autophagy

    (2011)
  • Y. Zou et al.

    Temozolomide induces autophagy via ATM‑AMPK‑ULK1 pathways in glioma

    Mol. Med. Rep.

    (2014)
  • L. Wang et al.

    Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms

    Cell Death Dis.

    (2017)
  • J. Lowe et al.

    Regulation of the Wip1 phosphatase and its effects on the stress response

    Front. Biosci.: J. Virtual Lib.

    (2012)
  • A. Brichkina et al.

    WIP-ing out atherosclerosis with autophagy

    Autophagy

    (2012)
  • X.-H. Zhan et al.

    MicroRNA16 regulates glioma cell proliferation, apoptosis and invasion by targeting Wip1-ATM-p53 feedback loop

    Oncotarget

    (2017)
  • X. Zhang et al.

    Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway

    Cancer Res.

    (2010)
  • X. Gao et al.

    MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2

    Oncol. Lett.

    (2019)
  • N. Huang et al.

    MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin

    Cancer Biol. Ther.

    (2015)
  • J. Brazina et al.

    DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase

    Cell Cycle

    (2015)
  • H. Sizek et al.

    Boolean model of growth signaling, cell cycle and apoptosis predicts the molecular mechanism of aberrant cell cycle progression driven by hyperactive PI3K

    PLoS Comput. Biol.

    (2019)
  • D. Deritei et al.

    A feedback loop of conditionally stable circuits drives the cell cycle from checkpoint to checkpoint

    Sci. Rep.

    (2019)
  • D. Voukantsis et al.

    Modeling genotypes in their microenvironment to predict single-and multi-cellular behavior

    GigaScience

    (2019)
  • D.A. Silveira et al.

    P53/E2F1/miR-25 axis regulates apoptosis induction in glioblastoma cells: a qualitative model

    J. Phys. Complex.

    (2020)
  • F.M. Khan et al.

    Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures

    Nat. Commun.

    (2017)
  • W. Abou-Jaoudé et al.

    Logical modeling and dynamical analysis of cellular networks

    Front. Genet.

    (2016)
  • A. Fauré et al.

    Dynamical analysis of a generic Boolean model for the control of the mammalian cell cycle

    Bioinformatics

    (2006)
  • D.A. Silveira et al.

    Dynamics of the feedback loops required for the phenotypic stabilization in the epithelial-mesenchymal transition

    FEBS J.

    (2020)
  • D. Thieffry

    Dynamical roles of biological regulatory circuits

    Brief. Bioinformatics

    (2007)
  • Cited by (36)

    • A novel risk signature based on autophagy-related genes to evaluate tumor immune microenvironment and predict prognosis in hepatocellular carcinoma

      2023, Computers in Biology and Medicine
      Citation Excerpt :

      As shown in Fig. 9F, patients with both BIRC5 and SNRPB positive expression had worse RFS than those with neither BIRC5 or SNRPB negative expression. Recently, increasing studies have demonstrated the involvement of autophagy in the occurrence and progression of various cancers [3,5,17]. Especially in HCC, one of the commonly diagnosed carcinomas with limited treatment options and poor prognosis, autophagy has been recognized to play an important role in tumorigenesis and tumor suppression [18].

    View all citing articles on Scopus
    1

    These authors contributed equally.

    2

    Present address: Department of Physics, Universidade Federal de Santa Maria, Santa Maria, 97105-900, Brazil

    View full text